ArticleQuantitative imaging in medicine and surgery2026
Terahertz meta-biosensor for bovine serum albumin sensing based on electromagnetic-induced transparency-like effect.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bovine serum albumin (BSA) sensing plays an important role in the diagnosis of various diseases, yet, there is still a lack of a cost-effective terahertz solution. Terahertz metamaterials based on electromagnetically induced transparency (EIT)-like effects show significant potential for biosensing due to their narrow transparent peak. This study aims to fabricate terahertz metamaterials based on EIT effect for non-destructive, trace-level detection of BSA. Methods: We demonstrate a multiband EIT-like metasurface that merges C-, toroidal, and D-shaped resonators to generate two transparency windows at 0.973 and 1.118 THz via strong bright-bright near-field coupling between adjacent resonators. Finite-element modelling was used to optimise the bright-bright near-field coupling before fabricating the 200-nm-contact-lithography device on a quartz substrate. A 100 µL aliquot of 0 to 6 mg/mL BSA solution was pipetted onto the metasurface. After drying at 50 ℃ for 20 min in an oven, the sample was measured with a terahertz time-domain spectrometer. The resonance shift was used to determine the sensitivity of the fabricated terahertz metamaterial for BSA detection and to calculate the limit of detection. Results: Simulated frequency sensitivity reached 222.6 GHz/RIU (refractive index unit) and 257.8 GHz/RIU at 0.973 and 1.118 THz, respectively. For BSA in water, the lower-frequency peak gave an experimental sensitivity of 14.43 GHz/(mg/mL) and 18.98 GHz/(mg/mL). The limit of detection was as low as 26.33 µg/mL and 20.02 µg/mL for the two transparency peaks, respectively. Conclusions: The chip-scale sensor merges foundry-compatible fabrication, dual-band operation and sub-picogram BSA resolution, offering an immediate upgrade path for point-of-care albumin assays and bioreactor monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.